Min Dong
-
- Viral-associated cancers and disorders 2
- Automotive Engineering top 10%
-
- Advanced Materials and Mechanics 4
-
- Lymphoma Diagnosis and Treatment 4
-
- Motivation and Self-Concept in Sports 3
-
- Medical Imaging Techniques and Applications 2
-
- RNA Interference and Gene Delivery 2
-
- Ferroptosis and cancer prognosis 2
-
- Cardiac Structural Anomalies and Repair 2
- Co-authors
- Zi Liang WuQiang ZhengJun YinYing HanMiao DuXing Peng HaoHai YuLinbo Wang
- Journals
- Advanced Materials (1 paper)Nature Materials (1 paper)SHILAP Revista de lepidopterología (3 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Min Dong
27 papers receiving 553 citations
Peers
Comparison fields: 5 of 85
- Cancer Research 115
- Molecular Medicine 34
- Oncology 140
- Biomaterials 61
- Automotive Engineering 55
Countries citing papers authored by Min Dong
This map shows the geographic impact of Min Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Dong more than expected).
Fields of papers citing papers by Min Dong
This network shows the impact of papers produced by Min Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Dong. The network helps show where Min Dong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Min Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 4 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 31 | |
| 9 | Egr1/HSP70 Promoter-Driven Activation of Gene Expression for Synergistic Anti-Hepatoma Using PEI-MZF Nanoparticles and Radiation | 2022 | 5 |
| 10 | 2022 | 21 | |
| 11 | 2021 | 36 | |
| 12 | 2020 | 4 | |
| 13 | 2020 | 16 | |
| 14 | 2018 | 24 | |
| 15 | 2014 | 12 | |
| 16 | 2014 | 8 | |
| 17 | 2012 | 63 | |
| 18 | 2011 | 34 | |
| 19 | 2011 | 12 | |
| 20 | [Update on myocardial bridging]. | 2006 | 0 |
About Min Dong
Min Dong is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 33 papers that have together received 562 indexed citations. Recurring topics across this work include Advanced Materials and Mechanics (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Motivation and Self-Concept in Sports (3 papers), Medical Imaging Techniques and Applications (2 papers), RNA Interference and Gene Delivery (2 papers), Ferroptosis and cancer prognosis (2 papers), Cardiac Structural Anomalies and Repair (2 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Cancer Research (115 citations), Molecular Medicine (34 citations) and Oncology (140 citations). Min Dong has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Zi Liang Wu, Qiang Zheng, Jun Yin, Ying Han, Miao Du, Xing Peng Hao, Hai Yu, Linbo Wang, Qiang Zheng and Hongyao Ding. Their work appears in journals such as Advanced Materials, Nature Materials and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.